Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Dementia Treatment Market Size Forecast: How Big Could The Market Get By 2030?
The dementia treatment market has experienced robust expansion in recent years. It will grow from $19.95 billion in 2025 to $21.81 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The historical growth can be linked to an aging global population, the increasing prevalence of Alzheimer’s disease, enhanced diagnosis rates, the sustained use of cholinesterase inhibitors, and the broadening of geriatric healthcare services.
The dementia treatment market is anticipated to experience robust expansion over the coming years. It is projected to reach a valuation of $31.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.3%. This projected growth during the forecast period is fueled by advancements in precision medicine approaches, an escalating demand for disease-modifying therapies, heightened investment in neurodegenerative research, the proliferation of homecare treatment models, and enhanced early diagnostic capabilities. Key trends shaping the market during this period encompass the greater embrace of combination drug therapies, an amplified focus on early-stage dementia intervention, the growing application of symptom management treatments, the broadening scope of non-pharmacological care methods, and a stronger emphasis on individualized treatment plans.
Get A Free Sample Report With In-Depth Market Insights:
Dementia Treatment Market Growth Drivers: What’s Behind The Acceleration?
An increasing occurrence of neurodegenerative conditions is anticipated to propel the expansion of the dementia treatment market in the foreseeable future. These disorders are characterized by the progressive deterioration and demise of nerve cells, resulting in escalating difficulties with movement, cognitive functions, or a combination of both. The surge in neurodegenerative conditions is primarily fueled by the demographic shift towards an older population, since extended lifespans heighten the probability of developing age-associated illnesses like Alzheimer’s and Parkinson’s disease, with age representing the paramount factor. A comprehensive understanding of neurodegenerative disorders improves dementia treatment by facilitating more accurate diagnoses and focused therapeutic strategies, because identifying the precise root cause permits a tailored and efficacious method for symptom management. For example, in April 2024, a report from the Alzheimer’s Association, a US-based non-profit health organization, indicated that around 6.9 million Americans aged 65 and older were living with Alzheimer’s dementia, and this count is expected to reach 13.8 million by 2060. Consequently, the increasing occurrence of neurodegenerative disorders is set to stimulate the expansion of the dementia treatment market.
Dementia Treatment Market Segmentation: How Does The Market Break Down By Category?
The dementia treatment market covered in this report is segmented –
1) By Treatment Type: Antipsychotics, Cholinesterase Inhibitors, Memantine
2) By Indication: Alzheimer’s Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia, Parkinson Disease Dementia, Other Indications
3) By Route of Administration: Oral, Transdermal Patch, Injectable
4) By Stage of Dementia: Mild Dementia, Moderate Dementia, Severe Dementia
5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Antipsychotics: Atypical Antipsychotics, Typical Antipsychotics
2) By Cholinesterase Inhibitors: Donepezil, Rivastigmine, Galantamine
3) By Memantine: Memantine Monotherapy, Memantine Combination Therapy
Dementia Treatment Market Trends: What’s Defining The Industry’s Next Phase?
Major companies operating in the dementia treatment market are prioritizing the creation of technologically advanced solutions, such as virtual reality (VR) training programs, to replicate complex and varied scenarios. Virtual reality training programs are engaging, computer-generated simulations that allow individuals to practice and refine skills within a controlled, interactive, and lifelike virtual environment. For instance, in September 2024, Otsuka Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company, collaborated with Jolly Good Inc., a Japan-based medical technology company, to introduce FACEDUO, a virtual reality training program for dementia care. This interactive VR tool, guided by medical experts, aids caregivers, including family members, in comprehending the emotions and behaviors of people with dementia. Simulating real-life scenarios enables caregivers to better respond to the unique needs of dementia patients. The program aims to enhance caregiving skills and empathy for more effective support.
Dementia Treatment Market Competitive Overview And Top Companies
Major companies operating in the dementia treatment market are Biogen Inc., Eisai Co. Ltd., Eli Lilly and Company, Roche Holding AG, AbbVie Inc., Sanofi S.A., Amgen Inc., Merz Pharmaceuticals GmbH, Acadia Pharmaceuticals Inc., Intra-Cellular Therapies Inc., Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Pfizer Inc., Novartis AG, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Cerevance Inc., AviadoBio Ltd., Cassava Sciences Inc., Anavex Life Sciences Corp.
View The Full Dementia Treatment Market Report:
Dementia Treatment Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the dementia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dementia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
